相关实验视频

Updated: Jul 4, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

氧化可诱导IgA脏病缓解与轻度至中度蛋白尿症:一个单重的回顾分析

Yixuan Pan¹, Jingyun Le¹, Lan Lan¹

¹Nephrology, Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, CHN.

|February 5, 2024

概括

氧化 (HCQ) 在IgA病 (IgAN) 患者中有效诱导缓解,患者有轻度至中度蛋白尿. 这项研究发现HCQ耐受性很好,与其他治疗方法相比,其安全性相当.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

收费类受体 (TLR) 信号传递和白细胞激活与IgA脏病 (IgAN) 病变发生有关.
基氨酸 (HCQ) 调节这些通路,表明其潜在的治疗作用.

研究的目的:

评估HCQ在IGAN患者中的疗效和安全性.
为了比较HCQ与氨酸- ангиотензин-阿尔多素系统抑制剂 (RAASi) 和皮质类固醇.

主要方法:

426名Igan患者的回顾性,单中心研究 (2016年5月 - 2020年8月).
倾向性得分匹配 (PSM) 创建了三个组:RAASi,皮质类固醇和HCQ (每组63名患者).
平均随访时间为11.03个月.

主要成果:

总缓解率为49.21% (RAASi),74.60% (皮质类固醇) 和52.38% (HCQ) (p=0.017). 总缓解率为49.21% (RAASi),74.60% (皮质类固醇) 和52.38% (HCQ) (p=0.017). 总缓解率为49.21% (RAASi),74.60% (皮质类固醇),和52.38% (HCQ) (p=0.017). 总缓解率为49.21% (RAASi),74.60% (皮质类固醇),和52.38% (HCQ) (p=0.017).
估计膜过率 (eGFR) >25%的下降发生在6.88%的患者中 (p=0.677).
一名HCQ患者的视力模糊,没有发现视网膜病变.

结论:

在Igan患者中,HCQ有效诱导轻度至中度蛋白尿的缓解.
在这种患者群体中,HCQ表现出良好的耐受性.

关键词:

不良事件不良事件不良事件氧化chloroquine 的使用情况伊加脏病是一种脏病.缓解率是因为缓解率.追溯分析是一种回顾性分析.

更多相关视频

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

相关概念视频

Factors Affecting Renal Clearance: Renal Impairment

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

Antihypertensive Drugs: Direct Renin Inhibitors

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...